AR123023A1 - Sensor de diagnóstico viral rápido - Google Patents

Sensor de diagnóstico viral rápido

Info

Publication number
AR123023A1
AR123023A1 ARP210102042A ARP210102042A AR123023A1 AR 123023 A1 AR123023 A1 AR 123023A1 AR P210102042 A ARP210102042 A AR P210102042A AR P210102042 A ARP210102042 A AR P210102042A AR 123023 A1 AR123023 A1 AR 123023A1
Authority
AR
Argentina
Prior art keywords
carousel
pandemic
viruses
rapid detection
probe
Prior art date
Application number
ARP210102042A
Other languages
English (en)
Inventor
Gerardine G Botte
Ashwin Ramanujam
Original Assignee
Univ Texas Tech System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas Tech System filed Critical Univ Texas Tech System
Publication of AR123023A1 publication Critical patent/AR123023A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
    • G01N33/48735—Investigating suspensions of cells, e.g. measuring microbe concentration
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G01N2333/163—Regulatory proteins, e.g. tat, nef, rev, vif, vpu, vpr, vpt, vpx
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3275—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Electrochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invención proporciona un dispositivo y un método para la detección rápida (en cuestión de segundos) de virus y viriones (proteínas y ácidos nucleicos) que se encuentran en el nuevo coronavirus (SARS-CoV-2), el virus de la inmunodeficiencia humana (VIH) y otros virus pandémicos. El dispositivo puede utilizarse en atención al público, hospitales, laboratorios clínicos, aeropuertos, tiendas de comestibles, hogares, y similares. El dispositivo puede utilizarse como una sola sonda para un solo uso o para uso doméstico, o el dispositivo integrado en un carrusel o un cargador de sondas múltiples para la detección rápida de múltiples muestras simultáneamente. Este carrusel facilitaría la realización de pruebas múltiples en tiempos de pandemia cuando hay que analizar un gran número de muestras en cortos períodos de tiempo.
ARP210102042A 2020-07-20 2021-07-20 Sensor de diagnóstico viral rápido AR123023A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16/933,686 US11060995B1 (en) 2020-07-20 2020-07-20 Rapid viral diagnostic sensor

Publications (1)

Publication Number Publication Date
AR123023A1 true AR123023A1 (es) 2022-10-26

Family

ID=76764599

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP210102043A AR123024A1 (es) 2020-07-20 2021-07-20 Sensor rápido de virus transmitidos por el aire y métodos relacionados con este
ARP210102042A AR123023A1 (es) 2020-07-20 2021-07-20 Sensor de diagnóstico viral rápido

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP210102043A AR123024A1 (es) 2020-07-20 2021-07-20 Sensor rápido de virus transmitidos por el aire y métodos relacionados con este

Country Status (8)

Country Link
US (1) US11060995B1 (es)
EP (1) EP4172619A1 (es)
AR (2) AR123024A1 (es)
AU (1) AU2021314082A1 (es)
BR (1) BR112023001225A2 (es)
CA (1) CA3186855A1 (es)
IL (1) IL300082A (es)
WO (2) WO2022020130A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11717273B1 (en) 2022-05-03 2023-08-08 Texas Tech University System System, method and apparatus for test kit for rapid viral diagnostic sensor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2519284A (en) 1946-10-07 1950-08-15 Phillips Petroleum Co Method of absorbing carbon monoxide
US5509410A (en) * 1983-06-06 1996-04-23 Medisense, Inc. Strip electrode including screen printing of a single layer
US5653864A (en) * 1994-06-30 1997-08-05 Nok Corporation Protein biosensor and method for protein measurement with the same
AU6114501A (en) * 2000-05-03 2001-11-12 Jen Gau Jr Biological identification system with integrated sensor chip
WO2012134408A1 (en) * 2011-03-31 2012-10-04 Argricultural Research Development Agency Electrochemical detection of capsaicinoid compounds in a sample
KR102216258B1 (ko) * 2014-09-02 2021-02-18 광주과학기술원 노로바이러스 검출 센서, 및 이를 이용하는 전기화학적 센싱방법
WO2020072446A1 (en) * 2018-10-01 2020-04-09 Ohio University Electrochemical microbial sensor

Also Published As

Publication number Publication date
WO2022020130A1 (en) 2022-01-27
AU2021314082A1 (en) 2023-03-02
AR123024A1 (es) 2022-10-26
BR112023001225A2 (pt) 2023-04-04
EP4172619A1 (en) 2023-05-03
CA3186855A1 (en) 2022-01-27
IL300082A (en) 2023-03-01
WO2022020127A1 (en) 2022-01-27
US11060995B1 (en) 2021-07-13

Similar Documents

Publication Publication Date Title
He et al. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines
Prescott et al. Postmortem stability of Ebola virus
Cohen et al. Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination
Verhagen et al. Epidemiology of influenza A virus among blackheaded gulls, the Netherlands, 2006-2010
EP3750916A3 (en) Anti-dengue virus ns1 protein monoclonal antibodies
van de Sandt et al. Human influenza A virus–specific CD8+ T-cell response is long-lived
Strindhall et al. Humoral response to influenza vaccination in relation to pre-vaccination antibody titres, vaccination history, cytomegalovirus serostatus and CD4/CD8 ratio
Tang et al. Cross-reactive antibodies to pandemic (H1N1) 2009 virus, Singapore
Dauner et al. The in vitro MIMIC® platform reflects age-associated changes in immunological responses after influenza vaccination
Gijzen et al. Standardization and validation of assays determining cellular immune responses against influenza
Salk et al. Granzyme B ELISPOT assay to measure influenza-specific cellular immunity
Laing et al. SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity
Pietschmann et al. Brief communication: magnetic immuno-Detection of SARS-CoV-2 specific antibodies
AR123023A1 (es) Sensor de diagnóstico viral rápido
Kuloğlu et al. Effect of BTN162b2 and CoronaVac boosters on humoral and cellular immunity of individuals previously fully vaccinated with CoronaVac against SARS‐CoV‐2: a longitudinal study
Kanji et al. Stability of SARS-CoV-2 IgG in multiple laboratory conditions and blood sample types
Law et al. Considerations for Choosing T Cell Assays during a Pandemic
Dowell et al. Primary Omicron infection elicits weak antibody response but robust cellular immunity in children
Maecker et al. T cell immunity to HIV: defining parameters of protection
WO2014126487A3 (en) Diagnosis and detection of dengue virus infection using chicken egg antibodies
Neale et al. CD4+ and CD8+ T cell and antibody correlates of protection against Delta vaccine breakthrough infection: A nested case-control study within the PITCH study
Claes et al. Evaluation of four enzyme-linked immunosorbent assays for the serologic survey of avian influenza in wild bird species
Furger et al. Humoral immune response to avian influenza vaccination over a six-month period in different species of captive wild birds
Dowall et al. Multiplex cytokine profiling with highly pathogenic material: Use of formalin solution in luminex analysis
Honce et al. Improved metabolic syndrome and timing of weight loss is crucial for influenza vaccine-induced immunity in obese mice